Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2003
09/25/2003WO2003079286A1 Medical applications of adaptive learning systems using gene expression data
09/25/2003WO2003079029A1 Positioning system for moving a selected station of a holding plate to a predetermined location for interaction with a probe
09/25/2003WO2003079025A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
09/25/2003WO2003079022A1 Ffluorescent reagent for selectively detecting double-stranded nucleic acid contianing fluorescent dye group and intercalate group
09/25/2003WO2003079020A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
09/25/2003WO2003079010A1 Fluorescent reagent cotanining fluorescent intercalator groups for detecting double-stranded nucleic acid
09/25/2003WO2003078965A2 System and method for measurement of a response of localized cellular compartments
09/25/2003WO2003078959A2 Methods for shp1 mediated neuroprotection
09/25/2003WO2003078662A1 Gene expression profiling in biopsied tumor tissues
09/25/2003WO2003078661A1 Method and kit for detection of mutations in mitochondrial dna
09/25/2003WO2003078660A2 Methods of identifying gene expression products resultant from alternative splicing and methods of diagnosing and treating disorders associated therewith
09/25/2003WO2003078659A2 Microcapsules with controlable permeability encapsulating a nucleic acid amplification reaction mixture and their use as reaction compartments for parallels reactions
09/25/2003WO2003078658A2 Methods for diagnosing and treating schizophrenia
09/25/2003WO2003078657A1 Methods and nucleic acids for the analysis of methylation within the gene melastatin
09/25/2003WO2003078656A2 Dna markers for cattle or beef products
09/25/2003WO2003078655A1 Method of detecting inorganic phosphoric acid, pyrophosphoric acid and nucleic acid and method of typing snp sequence of dna
09/25/2003WO2003078654A1 Device and method for detecting antibiotic inactivating enzymes
09/25/2003WO2003078653A1 Method and apparatus for monitoring a fermentation process
09/25/2003WO2003078651A2 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits
09/25/2003WO2003078650A2 Manganese ion regulation of reverse transcriptase activity and methods of modulating same
09/25/2003WO2003078649A2 Methods to increase nucleotide signals by raman scattering
09/25/2003WO2003078645A2 Methods for generating double stranded dna comprising a 3’ single stranded portion and uses of these complexes for recombination
09/25/2003WO2003078641A1 Engineered baculoviruses and their use
09/25/2003WO2003078638A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078631A1 Novel genes
09/25/2003WO2003078630A1 INHIBITION OF THE β3 SUBUNIT OF L-TYPE CA2+ CHANNELS
09/25/2003WO2003078625A2 An improved method for synthesising templated molecules
09/25/2003WO2003078623A1 Functional molecule and process for producing the same
09/25/2003WO2003078617A1 Production of usppase
09/25/2003WO2003078616A1 Production of ugppase
09/25/2003WO2003078613A2 Serine hydroxymethyltransferase as a target for herbicides
09/25/2003WO2003078603A2 Strong gene sets for glioma classification
09/25/2003WO2003078599A2 Method for generating primate trophoblasts
09/25/2003WO2003078593A2 Discovery and diagnostic methods using 5-methylcytosine dna glycosylase
09/25/2003WO2003078589A2 Method of identifying genes controlling diferentiation
09/25/2003WO2003078587A2 Nucleic acid detection method
09/25/2003WO2003078583A2 Optimization of crossover points for directed evolution
09/25/2003WO2003078582A2 Integrated system for high throughput capture of genetic diversity
09/25/2003WO2003078580A2 Imprinting in plants to control gene expression
09/25/2003WO2003078575A2 Molecular switches and methods for making and using the same
09/25/2003WO2003078573A2 Toll-like receptor 11
09/25/2003WO2003078570A2 Multiple controls for molecular genetic analyses
09/25/2003WO2003078565A1 Cell motility and chemotaxis test device and methods of using same
09/25/2003WO2003078469A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
09/25/2003WO2003078465A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
09/25/2003WO2003078452A1 Method and apparatus for the identification and qualification of biomolecules
09/25/2003WO2003078450A2 Negatively charged minor groove binders
09/25/2003WO2003078449A2 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins
09/25/2003WO2003078448A1 Modulation of protein methylation and phosphoprotein phosphate
09/25/2003WO2003078050A2 A building block forming a c-c bond upon reaction
09/25/2003WO2003078045A2 Microcapillary hybridization chamber
09/25/2003WO2003077998A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
09/25/2003WO2003077947A1 Methods of modulating cd200 receptors
09/25/2003WO2003077900A1 A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
09/25/2003WO2003077870A2 New strains of mycoplasma hyorhinis as causative agents for autoimmune disease
09/25/2003WO2003077868A2 Synthesis of synthons for the manufacture of bioactive compounds
09/25/2003WO2003077863A2 Method for overexpression of zwitterionic polysaccharides
09/25/2003WO2003077851A2 Compounds and methods for analyzing the proteome
09/25/2003WO2003077844A2 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria
09/25/2003WO2003077841A2 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases
09/25/2003WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/25/2003WO2003077729A2 Methods and compositions for identifying and characterizing hepatitis c
09/25/2003WO2003067252A3 Electrochemical biosensor strip for analysis of liquid samples
09/25/2003WO2003067251A3 Device for performing cell assays
09/25/2003WO2003058196A3 Multianalyte molecular analysis using application-specific random particle arrays
09/25/2003WO2003057240A3 Treatment and diagnosis of af4-dependant diseases
09/25/2003WO2003048732A3 Multiplexed methylation detection methods
09/25/2003WO2003048388A3 Immuno polymerase chain reaction assay
09/25/2003WO2003043487A3 Method of using a non-antibody protein to detect and measure an analyte
09/25/2003WO2003042411A3 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
09/25/2003WO2003042402A3 Agents that modulate immune cell activation and methods of use thereof
09/25/2003WO2003042245B1 Growth hormone variations in humans and their uses
09/25/2003WO2003040390A3 Protease assay for therapeutic drug monitoring
09/25/2003WO2003040295A3 Ion channel
09/25/2003WO2003033740A3 Apparatus and method for isolating a nucleic acid
09/25/2003WO2003031656A9 Genetic testing for male factor infertility
09/25/2003WO2003031644A3 Method for modelling hydrocarbon degradation in an oil deposit
09/25/2003WO2003020973A3 Polymorphic sex testing method
09/25/2003WO2003014746A3 Method for identifying proteins with n-terminal n-myristoylation
09/25/2003WO2003014387A3 Polymorphisms in the human gene for cyp1a2 and their use in diagnostic and therapeutic applications
09/25/2003WO2003013537A3 Irinotecan for treatment of cancer
09/25/2003WO2003013535A3 Use of irinotecan for improved treatment of cancer based on mdr1
09/25/2003WO2003012136A3 Method to detect splice variants of the calcineurin gene
09/25/2003WO2003012078A3 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
09/25/2003WO2003006956A3 Cell enumeration
09/25/2003WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof
09/25/2003WO2003002114A3 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
09/25/2003WO2003001968A3 Compositions and methods for inhibiting platelet activation and thrombosis
09/25/2003WO2003001210A3 Retrovirus associated with myelodysplastic syndromes
09/25/2003WO2003000907A3 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation
09/25/2003WO2002103043A3 Method for the specific fast detection of bacteria which is harmful to beer
09/25/2003WO2002102824A3 Method for specific fast detection of relevant bacteria in drinking water
09/25/2003WO2002101082A3 Culture medium for detecting and/or discriminating enterococcus and method therefor
09/25/2003WO2002100827A9 Method for increasing the survival of dopamine secreting cells
09/25/2003WO2002097059A9 Chromosome-based platforms
09/25/2003WO2002097049A3 Compositions and methods for binding agglomeration proteins
09/25/2003WO2002094850A3 Haplotypes of the gnrh2 gene
09/25/2003WO2002090584A3 Method for labelling and fragmenting dna
09/25/2003WO2002088736A3 Prenatal diagnosis method on isolated foetal cell of maternal blood
1 ... 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 ... 3003